Publicacións en colaboración con investigadores/as de Pfizer (United States) (2)

2020

  1. Cost-effectiveness analysis of second-line pharmacological treatment of acromegaly in Spain

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 20, Núm. 1, pp. 105-114

2019

  1. Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study

    Pituitary, Vol. 22, Núm. 2, pp. 137-145